Item # Length Source of Standard Year Implemented Version Implemented Year Retired Version Retired
3820 6 NAACCR 2018 18

NAACCR XML: Tumor.ceaPretreatmentLabValue

Description
CEA (Carcinoembryonic Antigen) Pretreatment Lab Value records the CEA value prior to treatment. CEA is a nonspecific tumor marker that has prognostic significance for colon and rectum cancer.
Rationale
CEA (Carcinoembryonic Antigen) Pretreatment Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum, CS SSF# 3.
Codes
0.00.0 nanograms/milliliter (ng/m) exactly
0.1-9999.90.1-9999.9 ng/ml
(Exact value to nearest tenth in ng/ml)
XXXX.110,000 ng/ml or greater
XXXX.7Test ordered, results not in chart
XXXX.8Not applicable: Information not collected for this case
(If this information is required by your standard setter, use of code XXXX.8 may result in an edit error.)
XXXX.9Not documented in medical record
CEA (Carcinoembryonic Antigen) Pretreatment Lab Value not assessed or unknown if assessed
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.